Lv53
1198 积分 2025-03-12 加入
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
2个月前
已完结
Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals
2个月前
已完结
Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats
2个月前
已完结
The antidiabetic drug teneligliptin induces vasodilation via activation of PKG, Kv channels, and SERCA pumps in aortic smooth muscle
2个月前
已完结
Comment on: Knop et al. (2007) Reduced Incretin Effect in Type 2 Diabetes: Cause or Consequence of the Diabetic State? Diabetes 56:1951–1959
4个月前
已完结
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
4个月前
已完结
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
4个月前
已完结
The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review
4个月前
已完结
Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects
4个月前
已完结
Effective management of a diabetic patient with hormone-receptor-positive, HER2‑negative metastatic breast cancer using nanosomal docetaxel lipid suspension for 12 cycles: A case report
5个月前
已完结
皖公网安备34019202002308
